Gene: FAM229B
Official Full Name: family with sequence similarity 229 member Bprovided by HGNC
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO17726 | FAM229B Knockout cell line (HeLa) | Human | FAM229B | 1:3~1:6 | Negative | Online Inquiry |
KO17727 | FAM229B Knockout cell line (HCT 116) | Human | FAM229B | 1:2~1:4 | Negative | Online Inquiry |
KO17728 | FAM229B Knockout cell line (HEK293) | Human | FAM229B | 1:3~1:6 | Negative | Online Inquiry |
KO17729 | FAM229B Knockout cell line (A549) | Human | FAM229B | 1:3~1:4 | Negative | Online Inquiry |
FAM229B Gene Knockout Cell Lines are specially developed cellular models that have undergone precise genetic modification to disrupt the FAM229B gene. This gene has emerged as an important factor in various cellular processes, potentially playing a role in cancers and other diseases. In these knockout models, the complete elimination of FAM229B expression allows researchers to observe specific cellular responses and molecular pathways, facilitating the dissection of the gene's role in biological processes.
The key function of FAM229B Gene Knockout Cell Lines lies in their ability to provide clear insights into gene function and interaction networks. By examining the phenotypic and biochemical changes that occur in the absence of FAM229B, researchers can elucidate its role in cellular signaling, proliferation, and apoptosis. This can significantly enhance the understanding of FAM229B's associations with disease mechanisms, offering potential avenues for therapeutic intervention.
The scientific importance of these knockout cell lines extends to various research applications, including drug development, genetic studies, and cancer research, as they serve as valuable tools for testing hypotheses regarding gene function. In clinical settings, they can assist in identifying biomarkers for patient stratification or therapeutic responses.
FAM229B Gene Knockout Cell Lines provide distinct advantages over traditional models, including greater specificity in understanding gene function and the ability to generate reproducible results that better represent human biology. Unlike alternatives that may still express partial gene functions, these knockout lines ensure the complete absence of the FAM229B gene, leading to more reliable experimental outcomes.
For researchers and clinicians aiming to advance their understanding of gene function and disease pathology, these knockout cell lines present an invaluable resource. Their precise genetic modifications are backed by rigorous validation processes, ensuring that users receive a product of the highest quality. At [Your Company Name], our commitment to cutting-edge scientific innovation and expertise in genetic engineering ensures that we provide researchers with top-tier tools to accelerate their discoveries.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.